{
  "nodes": [
    {
      "id": "node_001",
      "content": "T1\u20133, N1 nodes positive, M0",
      "parent_ids": [],
      "children_ids": [
        "node_002",
        "node_003"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_002",
      "content": "Operable",
      "parent_ids": [
        "node_001"
      ],
      "children_ids": [
        "node_004"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_003",
      "content": "Medically inoperable, high surgical risk as determined by thoracic surgeon,m and those who decline surgery after thoracic surgical consultation",
      "parent_ids": [
        "node_001"
      ],
      "children_ids": [
        "node_005"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "m"
      ]
    },
    {
      "id": "node_004",
      "content": "Surgical resectionm + mediastinal lymph node dissection or systematic lymph node sampling after preoperative systemic therapy, if plannedq",
      "parent_ids": [
        "node_002"
      ],
      "children_ids": [
        "node_006"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "m",
        "q"
      ]
    },
    {
      "id": "node_005",
      "content": "Definitive concurrent chemoradiationn,t (category 1)",
      "parent_ids": [
        "node_003"
      ],
      "children_ids": [
        "node_007"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "n",
        "t"
      ]
    },
    {
      "id": "node_006",
      "content": "Findings at Surgery (NSCL-4)",
      "parent_ids": [
        "node_004"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-4"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_007",
      "content": "Durvalumabt,v (if no EGFR exon 19 deletion or L858R) (category 1 stage III; category 2A stage II) or Osimertinibt,v (if EGFR exon 19 deletion or L858R) (category 1 stage III; category 2A stage II)",
      "parent_ids": [
        "node_005"
      ],
      "children_ids": [
        "node_008"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "t",
        "v"
      ]
    },
    {
      "id": "node_008",
      "content": "Surveillance (NSCL-17)",
      "parent_ids": [
        "node_007"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-17"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_009",
      "content": "T1\u20133, N2 nodes positive, M0",
      "parent_ids": [],
      "children_ids": [
        "node_010",
        "node_011"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_010",
      "content": "Definitive concurrent chemoradiationn,t (category 1)",
      "parent_ids": [
        "node_009"
      ],
      "children_ids": [
        "node_012"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "n",
        "t"
      ]
    },
    {
      "id": "node_011",
      "content": "or Systemic therapyq,y \u00b1 RTn",
      "parent_ids": [
        "node_009"
      ],
      "children_ids": [
        "node_013",
        "node_014"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "q",
        "y",
        "n"
      ]
    },
    {
      "id": "node_012",
      "content": "Durvalumabt,v (if no EGFR exon 19 deletion or L858R) (category 1) or Osimertinibt,v (if EGFR exon 19 deletion or L858R) (category 1)",
      "parent_ids": [
        "node_010"
      ],
      "children_ids": [
        "node_015"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "t",
        "v"
      ]
    },
    {
      "id": "node_013",
      "content": "No apparent progressionz",
      "parent_ids": [
        "node_011"
      ],
      "children_ids": [
        "node_016",
        "node_017"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "z"
      ]
    },
    {
      "id": "node_014",
      "content": "Progressionz",
      "parent_ids": [
        "node_011"
      ],
      "children_ids": [
        "node_018",
        "node_019"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "z"
      ]
    },
    {
      "id": "node_015",
      "content": "Surveillance (NSCL-17)",
      "parent_ids": [
        "node_012"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-17"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_016",
      "content": "Surgerym",
      "parent_ids": [
        "node_013"
      ],
      "children_ids": [
        "node_020"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "m"
      ]
    },
    {
      "id": "node_017",
      "content": "Consider RTn",
      "parent_ids": [
        "node_013"
      ],
      "children_ids": [
        "node_021"
      ],
      "tree_ids": [],
      "footnote_labels": [
        "n"
      ]
    },
    {
      "id": "node_018",
      "content": "Local",
      "parent_ids": [
        "node_014"
      ],
      "children_ids": [
        "node_022"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_019",
      "content": "Systemic",
      "parent_ids": [
        "node_014"
      ],
      "children_ids": [
        "node_023"
      ],
      "tree_ids": [],
      "footnote_labels": []
    },
    {
      "id": "node_020",
      "content": "Findings at Surgery (NSCL-4)",
      "parent_ids": [
        "node_016"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-4"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_021",
      "content": "Surveillance (NSCL-17)",
      "parent_ids": [
        "node_017"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-17"
      ],
      "footnote_labels": []
    },
    {
      "id": "node_022",
      "content": "RTn (if feasible) \u00b1 chemotherapyq",
      "parent_ids": [
        "node_018"
      ],
      "children_ids": [],
      "tree_ids": [],
      "footnote_labels": [
        "n",
        "q"
      ]
    },
    {
      "id": "node_023",
      "content": "Treatment for Metastasis limited sites (NSCL-15) or distant disease (NSCL-18)",
      "parent_ids": [
        "node_019"
      ],
      "children_ids": [],
      "tree_ids": [
        "NSCL-15",
        "NSCL-18"
      ],
      "footnote_labels": []
    }
  ],
  "tree_references": [
    {
      "from_tree": "NSCL-10",
      "to_tree": "NSCL-4",
      "description": "Next steps based on Findings at Surgery"
    },
    {
      "from_tree": "NSCL-10",
      "to_tree": "NSCL-17",
      "description": "Surveillance protocol"
    },
    {
      "from_tree": "NSCL-10",
      "to_tree": "NSCL-15",
      "description": "Treatment for Metastasis limited sites"
    },
    {
      "from_tree": "NSCL-10",
      "to_tree": "NSCL-18",
      "description": "Treatment for Metastasis distant disease"
    }
  ],
  "footnotes": [
    {
      "label": "m",
      "content": "Principles of Surgical Therapy (NSCL-B)."
    },
    {
      "label": "n",
      "content": "Principles of Radiation Therapy (NSCL-C)."
    },
    {
      "label": "q",
      "content": "Perioperative Systemic Therapy (NSCL-E)."
    },
    {
      "label": "t",
      "content": "Concurrent Chemoradiation Regimens (NSCL-F)."
    },
    {
      "label": "v",
      "content": "For patients who have received sequential chemoradiation, durvalumab can be considered as consolidation immunotherapy or, if EGFR exon 19 deletion or L858R, osimertinib is recommended."
    },
    {
      "label": "y",
      "content": "Selected patients with N2 disease (fit, single-station, non-bulky N2, requiring only lobectomy) may be considered for systemic therapy followed by surgery."
    },
    {
      "label": "z",
      "content": "Chest CT with contrast and/or FDG-PET/CT to evaluate progression."
    },
    {
      "label": "Note",
      "content": "All recommendations are category 2A unless otherwise indicated."
    }
  ],
  "extraction_confidence": 0.95,
  "image_title": "NCCN Guidelines Version 3.2025 Non-Small Cell Lung Cancer",
  "tree_id": "NSCL-10"
}